Ann: Progress in Recruitment for Phase II Trial in Dogs, page-28

All, this may be a dumb point, and please correct me, but my understanding is that dogs with lymphoma B typically don't have long to live, so wouldn't recruiting them months early in readiness for trial administration agreements and ethics sign-offs etc be too late - tragically they just would not be alive or have a good prospect of living long enough (say 6 weeks) to complete a trial.

If that is the case, then I believe the status of play is understandable because early stage diagnosed dogs need to be available for this trial. If not we risk testing this new drug properly and boxing at shadows and diluting outcomes based on inconclusive results.

I think many of us had not appreciated that a couple of months ago, I had not. The learning is that PAA could have communicated that roadmap, plan and its design controls a little better so more people were less shocked and unnerved by an apparent delay with no explanation.

Regardless, I think management are doing a good job and I am excited at the prospect of trials starting in the near term.

GLTAH QQ